Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | 85.95 |
|---|---|
| High | 85.95 |
| Low | 85.95 |
| Bid | 83.05 |
| Offer | 83.76 |
| Previous close | 85.95 |
| Average volume | -- |
|---|---|
| Shares outstanding | 49.74m |
| Free float | 49.46m |
| P/E (TTM) | -- |
| Market cap | 989.86m USD |
| EPS (TTM) | -1.96 USD |
Data delayed at least 15 minutes, as of Dec 16 2021.
More ▼
Press releases
- STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
- STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
- FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
- STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
- STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
- Alcon Terminates Agreement to Acquire STAAR Surgical
- Alcon Terminates Agreement to Acquire STAAR Surgical
- Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
- STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
- Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
More ▼
